loader
Please Wait
Applying Filters...

Evonik Evonik

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    List of Certificates of Suitability (CEPs) for r1_cep_2003_018___rev_02 Active Pharmaceutical Ingredient (API) issued by the EDQM. Original Data: EDQM Database

    Client Virtual Booth
    Menu

    Debiopharm

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    DOSSIERs // Finished Dosage Forms

    PharmaCompass

    Minakem offers CDMO services for API & HPAPI, generics, regulatory expertise, track record performance & FDA & GMP certifications.

    Send me more info on How To Grow My Business Digitally?

    Left Arrow
    Right Arrow
    Filters Filter
    Cross PopUp
    FILTER :

    filter

    01 DEBIOPHARM INTERNATIONAL S.A. Lausanne CH (1)

    filter

    01 Oxaliplatin (1)

    filter

    01 Switzerland (1)

    filter

    01 Withdrawn by Holder (1)

    ListList of Suppliers
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us

    DEBIOPHARM INTERNATIONAL S.A. Lausa...

    Contact Supplier
      Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
      Post an Enquiry Post an Enquiry
      Flag Switzerland
      Virtual Booth Virtual Booth
      Digital Content Digital Content

      Oxaliplatin

      PDF Supplier PDF
      URL Supplier Web Content
      R1-CEP 2003-018 - Rev 02
      Withdrawn by Holder
      Chemical
      2013-07-23
      2018-03-27
      2017
      ASK
      US
      PHARMACOMPASS
      Upload
      your Marketing & Sales content

      Looking for Certificates of Suitability (CEPs) for R1-CEP 2003-018 - Rev 02 of Debiopharm International S.a. Lausanne Ch

      Looking for Certificates of Suitability (CEPs) for R1-CEP 2003-018 - Rev 02 of Debiopharm International S.a. Lausanne Ch 1

      20

      Debiopharm International S.a. Lausanne Ch, based in Switzerland, is a pharmaceutical company.

      One of their significant offerings is Oxaliplatin, supported by a 'Withdrawn by Holder' Certificate of Suitability (CEP) with the number R1-CEP 2003-018 - Rev 02

      This Chemical Type CEP, issued on July 23, 2013, remains in force until March 27, 2018, ensuring its reliability within the pharmaceutical industry.

      Substance Number 2017 associated with this CEP further emphasizes

      Post Enquiry
      POST ENQUIRY